Penumbra today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra System with ACE68 and ACE64 reperfusion catheters as frontline treatment in patients with acute ischemic stroke using the ADAPT (a direct aspiration first pass technique)
silver5max_ace_main.jpg
